Test filters | DNDi

News

In the media

Press releases

Publications

Scientific articles

Statements

Stories

Videos

Viewpoints

In the media

27 Feb 2026

La maladie du sommeil bientôt éliminée ? Feu vert européen à un nouveau traitement

France 24

In the media

27 Feb 2026

‘Truly spectacular’ drug for sleeping sickness simplifies treatment, raising hopes for eradication

Science

Scientific articles

26 Feb 2026

A Computational Community Blind Challenge on Pan-Coronavirus Drug Discovery Data

Journal of Chemical Information and Modeling

In the media

26 Feb 2026

被忽视疾病的希望

China Philanthropy Magazine

Scientific articles

24 Feb 2026

Elimination of visceral leishmaniasis as a public health problem in Bangladesh: Lessons learned and questions remaining

PLOS Neglected Tropical Diseases

Scientific articles

24 Feb 2026

Prevalence of Chlamydia trachomatis and Neisseria gonorrhoeae infections and associated risk factors among pregnant women and key populations in Kenya: A multi-centre cross-sectional study

PLOS Global Public Health

News

20 Feb 2026

DNDi welcomes GHIT support for lead identification of a novel chemical series in the Eisai-led Chagas disease project

Scientific articles

18 Feb 2026

Pharmacokinetics, safety, and tolerability of an oxfendazole tablet formulation: a phase 1, randomized, placebo-controlled trial in healthy African volunteers

Antimicrobial Agents Chemotherapy

In the media

17 Feb 2026

Still no specific treatment for dengue despite global risk

The Sun

Press releases

10 Feb 2026

DNDi and Dubai Health launch Middle East partnership to advance research and training in neglected diseases

Statements

10 Feb 2026

Statement on Brazil’s draft National Action Plan for Antimicrobial Resistance

Scientific articles

9 Feb 2026

Repurposing oxfendazole for onchocerciasis: Population pharmacokinetics of a tablet formulation in healthy African adults

CPT: Pharmacometrics & Systems Pharmacology

In the media

8 Feb 2026

Neglected killer: Kala-azar disease surges in Kenya

France 24

In the media

4 Feb 2026

Leishmaniasis: a story of two continents

The Lancet

Statements

3 Feb 2026

DNDi interventions at the 158^th Session of the WHO Executive Board

Scientific articles

3 Feb 2026

Evaluation of quality of care in Chagas disease cardiomyopathy

Global Heart

International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

La maladie du sommeil bientôt éliminée ? Feu vert européen à un nouveau traitement

‘Truly spectacular’ drug for sleeping sickness simplifies treatment, raising hopes for eradication

A Computational Community Blind Challenge on Pan-Coronavirus Drug Discovery Data

被忽视疾病的希望

Elimination of visceral leishmaniasis as a public health problem in Bangladesh: Lessons learned and questions remaining

Prevalence of Chlamydia trachomatis and Neisseria gonorrhoeae infections and associated risk factors among pregnant women and key populations in Kenya: A multi-centre cross-sectional study

DNDi welcomes GHIT support for lead identification of a novel chemical series in the Eisai-led Chagas disease project

Pharmacokinetics, safety, and tolerability of an oxfendazole tablet formulation: a phase 1, randomized, placebo-controlled trial in healthy African volunteers

Still no specific treatment for dengue despite global risk

DNDi and Dubai Health launch Middle East partnership to advance research and training in neglected diseases

Statement on Brazil’s draft National Action Plan for Antimicrobial Resistance

Repurposing oxfendazole for onchocerciasis: Population pharmacokinetics of a tablet formulation in healthy African adults

Neglected killer: Kala-azar disease surges in Kenya

Leishmaniasis: a story of two continents

DNDi interventions at the 158^th Session of the WHO Executive Board

Evaluation of quality of care in Chagas disease cardiomyopathy

Learn more

Get in touch

Support us

Work with us